Company intelligence / Profile preview

mySugr

Vienna, Vienna, Austriamysugr.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

mySugr offers a globally available digital health platform for people with diabetes. The app integrates blood glucose readings from connected devices (such as Accu-Chek meters), allows manual entry of meals/insulin/activity/medication data, provides analytics to identify trends in glycemic control, supports remote sharing with healthcare teams via the Roche Diabetes Care Platform, and includes features like bolus calculators in some regions. It has over four million registered users worldwide.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Roche Diabetes Care / Accu-Chek integrationAscensia Diabetes Care device compatibility in some marketsInsurance partnerships for bundled offerings in select regions

Beyond the preview

Go deeper on mySugr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mySugr.

Explore the full profile